Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer (OPEN)
Sponsor: Cancer Australia Priority-driven Collaborative Cancer Research Scheme
Listed as NCT00850772, this PHASE3 trial focuses on Epithelial Ovarian Cancer and Fallopian Tube Cancer and remains completed. Sponsored by Cancer Australia Priority-driven Collaborative Cancer Research Scheme, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Australia Priority-driven Collaborative Cancer Research Scheme
- Queensland Centre for Gynaecological Cancer
- The University of Queensland
For direct contact, visit the study record on ClinicalTrials.gov .